Xenon Pharmaceuticals

XENE59

$38.47arrow_drop_down3.46%-$1.38

XENE59

$38.47

arrow_drop_down3.46%-$1.38

Performance History

Key Stats
Open	$39.71
Prev. Close	$39.85
EPS	-2.73
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

PE Ratio	-

	LOW	HIGH
Day Range	38.47	40.03
52 Week Range	27.98	50.99

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-2.73

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Xenon Pharmaceuticals (XENE)

Xenon Pharmaceuticals Inc. (XENE) is a pharmaceutical company focused on the discovery and development of innovative therapeutics for neurological disorders. The company's primary objective is to improve the lives of patients suffering from diseases such as epilepsy, migraine, and Alzheimer's. With a strong emphasis on precision medicine, Xenon utilizes its proprietary drug discovery platform to identify and target specific genetic variations that play a role in these disorders.

Xenon's stock price history reflects the company's commitment to scientific excellence and innovation. Over the years, the stock has shown significant growth, driven by positive clinical trial results and successful partnerships. Investors have recognized the potential of Xenon's pipeline of novel therapeutics, leading to a continuous increase in the stock price.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Mr. Ian C. Mortimer C.M.A., CPA, CMA, CPA, M.B.A., MBA
Headquarters: Burnaby
Employees: 203
Exchange: NASDAQ

Keep an eye on Xenon Pharmaceuticals

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Xenon Pharmaceuticals 's (XENE) price per share?

The current price per share for Xenon Pharmaceuticals (XENE) is $38.47. The stock has seen a price change of -$1.38 recently, indicating a -3.46% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Xenon Pharmaceuticals (XENE)?

For Xenon Pharmaceuticals (XENE), the 52-week high is $50.99, which is 32.54% from the current price. The 52-week low is $27.98, the current price is 37.47% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Xenon Pharmaceuticals (XENE) a growth stock?

Xenon Pharmaceuticals (XENE) has shown an average price growth of 0.41% over the past three years. It has received a score of 87 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Xenon Pharmaceuticals as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Xenon Pharmaceuticals (XENE) stock price performance year to date (YTD)?

As of the latest data, Xenon Pharmaceuticals (XENE) has a year-to-date price change of -14.34%. Over the past month, the stock has experienced a price change of -8.4%. Over the last three months, the change has been 1.69%. Over the past six months, the figure is -16.3%. Looking at a longer horizon, the five-year price change stands at 295.38%.

help

Is Xenon Pharmaceuticals (XENE) a profitable company?

Xenon Pharmaceuticals (XENE) has a net income of -$182.39M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$214.05M. Furthermore, the EBITDA is -$233.68M.

help

What is the market capitalization of Xenon Pharmaceuticals (XENE)?

Xenon Pharmaceuticals (XENE) has a market capitalization of $3.02B. The average daily trading volume is 255.95K, indicating the stock's liquidity and investor engagement.

News

7/2/2024

Longboard (LBPH) Up 14% as Epilepsy Drug Gets Breakthrough Tag

Xenon Pharmaceuticals Presents Data from Phase 2 X-NOVA Clinical Trial of Azetukalner in Major Depressive Disorder at the American Society of Clinical Psychopharmacology 2024 Annual Meeting

CALENDAR OF EVENTS

CLINICAL STUDY

5/28/2024

Xenon Pharmaceuticals Presents Data from Phase 2 X-NOVA Clinical Trial of Azetukalner in Major Depressive Disorder at the American Society of Clinical Psychopharmacology 2024 Annual Meeting

5/10/2024

Xenon (XENE) Q1 Earnings Beat Estimates, Pipeline in Focus